Clinical and genetic analysis of patients with cystinuria in the united kingdom

51Citations
Citations of this article
74Readers
Mendeley users who have this article in their library.

Abstract

Background and objectives Cystinuria is a rare inherited renal stone disease. Mutations in the amino acid exchanger System b0,+, the two subunits of which are encoded by SLC3A1 and SLC7A9, predominantly underlie this disease. Thework analyzed the epidemiology of cystinuria and the influence ofmutations in these two genes on disease severity in a United Kingdom cohort. Design, setting, participants, & measurements Prevalent patients were studied from2012 to 2014 in the northeast and southwest of the United Kingdom. Clinical phenotypes were defined, and genetic analysis of SLC3A1 and SLC7A9 combining Sanger sequencing and multiplex ligation probe-dependent amplification was performed. Results In total, 76 patients (42 men and 34women)were studied. All subjects had proven cystine stones. Median age of presentation (first stone episode)was 24 years old, but 21%of patients presented after 40 years old. Patients had varied clinical courses, with 37% of patients having ≥ 10 stone episodes; 70% had evidence of CKD, and 9% had reached ESRD as a result of cystinuria and its complications. Patients with cystinuria received a variety of different therapies, with no obvious treatment consensus. Notably, 20% of patients had staghorn calculi, with associated impaired renal function in 80% of these patients. Genetic analysis revealed that biallelic mutations were present in either SLC3A1 (n=27) or SLC7A9 (n=20); 22 patients had only one mutated allele detected (SLC3A1 in five patients and SLC7A9 in 17 patients). In total, 37 different mutant variant alleles were identified, including 12 novel mutations; 22% of mutations were caused by large gene rearrangements. No genotypephenotype association was detected in this cohort. Conclusions Patientswith cystinuria in theUnited Kingdomoften present atypicallywith staghorn calculi at ≥ 40 years old and commonly develop significant renal impairment. There is no association of clinical course with genotype. Treatments directed toward reducing stone burden need to be rationalized and developed to optimize patient care.

Cite

CITATION STYLE

APA

Rhodes, H. L., Yarram-Smith, L., Rice, S. J., Tabaksert, A., Edwards, N., Hartley, A., … Coward, R. J. M. (2015). Clinical and genetic analysis of patients with cystinuria in the united kingdom. Clinical Journal of the American Society of Nephrology, 10(7), 1235–1245. https://doi.org/10.2215/CJN.10981114

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free